ABL Diagnostics

Company Description

---

Advanced Biological Laboratories (ABL), S.A., is a diagnostic and medical software company founded in 2000 as a spin-off from CRP-Santé (https://www.lih.lu/) Luxembourg.

ABL’s products offer to infectious disease clinicians, virology and microbiology laboratories.

Assays and standalone software systems for accredited laboratories (i.e. ISO 15189), mainly for microbiology applications (related to HIV, SARS-CoV-2, Tuberculosis, HCV, HBV, HPV, CMV, HPV, Flu, 16s RNA…) for clinical genotyping through sequencing (DeepChek®), DNA and RNA detection and quantification (UltraGene®), including powerful downstream analysis software applications fully integrated with knowledge databases and analysis systems for capillary and high-throughput Next Generation Sequencing data.

Clinical software applications for infectious diseases units

IT dashboards and clinical database aggregation applications for research and clinical management

Year founded

---

2000

Served area

---

Worldwide

Headquarters

---

Bât E1 42 Rue Olivier Métra, 75020 Paris – France

Shares outstanding

---

2,006,480

IPO

---

Jan. 1, 2020

Stock exchange(s)

---

Euronext Paris